About Us

N
e
o
n
a
t
a
l
J
a
u
n
d
i
c
e

Globally, Healthcare providers worldwide recognize that severe neonatal jaundice is a “silent” cause of significant neonatal morbidity and mortality.
01.

New born baby care

02.

nLite your baby health

black-arrow Know More

Over 60% of all newborns develop neonatal jaundice

0 +

Around 15% to 45% of newborns develop severe neonatal jaundice in developing countries

0 +

Around 10% of newborns die due to neonatal jaundice all over the world

0 K

Almost 20% of the jaundice babies in india alone ,die due to severe neonatal jaundice

0 +

Our Solutions

H
i
g
h
Q
u
a
l
i
t
y
S
o
l
u
t
i
o
n
s
f
o
r
n
e
w
b
o
r
n
b
a
b
i
e
s
.

Introducing A smart Design approached technology
A Revolutionary Phototherapy device for neonatal jaundice management.

Challenges

C
u
r
r
e
n
t
T
r
e
a
t
m
e
n
t
C
h
a
l
l
e
n
g
e
s

SLOW TREATMENT
01

SLOW TREATMENT

Existing treatments result in a prolonged 2-3 week delay, impacting timely care for infants.
SEVERE JAUNDICE CONDITION
02

SEVERE JAUNDICE CONDITION

Blood transfusion and current indigenous methods fall short in effectively addressing severe jaundice cases.
POST-NATAL SEPARATION
03

POST-NATAL SEPARATION

Immediate separation after birth causes anxiety and disrupts the crucial initial bond between newborns and mothers.
LOW EFFICIENCY
04

LOW EFFICIENCY

Treatment efficiency is hindered by factors such as suboptimal irradiance, inadequate body surface exposure, and insufficient breastfeeding.

Home Phototherapy

Neonatal care at your Doorstep From an IIT Hyderabad startup

*Ensuring Newborn Joy under Expert Guidance

People Trusted

O
u
r
P
a
r
t
n
e
r
i
n
g
D
o
c
t
o
r

DR. SWAPNA. LINGALDINNA


Associate PROFESSOR OF NEONATOLOGY NILOUFER HOSPITAL, HYDERABAD.

“I’m thrilled to partner with HEAMAC! Their innovative phototherapy devices have significantly improved newborn care, and I’m proud to be part of this journey.”

Heamac

S
u
p
p
o
r
t
e
d
B
y

Heamac

O
u
r
C
l
i
e
n
t
s

1
2
3
Phone Icon WhatsApp Icon Appointment Icon